HomeSRTOY • OTCMKTS
add
Sartorius Stedim Biotech S A Unsponsored France ADR
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 751.30M | 6.30% |
Operating expense | 231.40M | 80.92% |
Net income | 45.60M | 12.87% |
Net profit margin | 6.07 | 6.12% |
Earnings per share | 1.03 | 43.06% |
EBITDA | 165.50M | 19.06% |
Effective tax rate | -13.20% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 678.90M | 438.38% |
Total assets | 8.26B | 6.81% |
Total liabilities | 4.23B | -16.29% |
Total equity | 4.02B | — |
Shares outstanding | 97.04M | — |
Price to book | 0.53 | — |
Return on assets | 2.61% | — |
Return on capital | 3.11% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 45.60M | 12.87% |
Cash from operations | 284.90M | -15.21% |
Cash from investing | -80.20M | 23.76% |
Cash from financing | -11.40M | 94.67% |
Net change in cash | 196.40M | 1,035.26% |
Free cash flow | 241.42M | 92.24% |
About
Founded
1978
Website
Employees
9,901
